Bharat Biotech International Ltd, vaccines manufacturer, today said it is in the process of setting up a Rs 100-crore unit near Bangalore that will manufacture 100 million doses of animal vaccines.
"The new unit, to be commissioned in two months, will have a production capacity of 100 million doses of vaccine for cattle and other animals," company's Chairman and Managing Director Krishna M Ella told PTI.
The main product of the new venture, to be called BIO-VET International Limited, would be a vaccine for the foot and mouth disease prevalent among cattles, he said.
Ella said the company was all set to garner a business of over Rs 400 crore in the current fiscal compared to Rs 300 crore in 2008-09.
In the last one and a half years, BBIL had supplied 500 million doses of polio vaccine to the country, he said.
On the export front, BBIL, the largest manufacturer of Hepatitis-B vaccines, clinched Rs 80 crore worth orders, supplying various types of vaccines to over 65 countries, he said.
Ella claimed that BBIL was the only bio-tech company to export two million tonnes of preservative free vaccines to regulated markets across the globe.
